Digipath
Home > Boards > US OTC > Biotechs >

OncoVista Innovative Therapies, Inc. (OVIT)

OVIT RSS Feed
Add OVIT Price Alert      Hide Sticky   Hide Intro
Moderator: sharkgroupsn, gi197845
Search This Board: 
Last Post: 1/17/2019 5:33:30 PM - Followers: 19 - Board type: Free - Posts Today: 0

OncoVista Innovative Therapies, Inc. (OVIT) 

 

Please see the bottom of the iBox for a contrary view on this stock.

 

http://www.oncovista.com/

 

 

Company Information:

OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio,, TX 78245

Phone: 210-677-6000

 

CIK:  0001094847

The latest 10Q can be found here: http://filings.issuerdirect.com/data/1094847/000114420411063209/v240119_10q.pdf

Link to clinical trials register: http://www.clinicaltrials.gov/ct2/results?term=cordycepin 

Neither of the two cordycepin studies registered with clinical.trials.gov has been updated for over two years, which is a breach of registration conditions.

 

 

OncoVista Innovative Therapies, Inc., is a bio-pharmaceutical company that claims to be dedicated to providing innovative, safe and efficacious treatments for cancer through the use of biomarkers in order to extend and improve the quality of life for patients.

Based in San Antonio, Texas, OncoVista was incorporated in 2004 and says it utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs. Although no such drugs have yet been brought to market, and the "incubator" behind Onco Vista, Technology Innovations, LLC, has a long and inglorious history of transferring monies from its publicly held spin-offs such as Biophan and Natural Nano into private hands.

 

Management: 

http://www.oncovista.com/index.php?option=com_content&task=view&id=67

 

 

Claims made by Onco Vista regarding its Core Capabilities for Accelerated Drug Development

Lipitek International
Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite

UT Health Science Center (Prof. Luduena)
Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays

University of Alberta (Prof. Tuszynski)
Molecular modeling, computer simulation of new molecules, molecule design and in silico screening

AAI Oncology (Paris)
Global oncology-focused clinical Contract Research Organization (CRO)

Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD)
In vitro and in vivo capabilities; Phase I/II clinical trials

Other Local Resources (nothing to do with Onco Vista per se: probably included here to give an impression of referred respectability).
Southwest Oncology Group
Southwest Foundation for Biomedical Research

 

 

 

Press Releases:  
http://www.oncovista.com/index.php?option=com_content&task=view&id=91

http://finance.yahoo.com/q/h?s=OVIT.OB+Headlines

 

 

-----------------------

 

 

 

AdnaGen

http://www.adnagen.com/

 

News from AdnaGen site, which is majority owned by OVIT

http://www.adnagen.com/HTML_Dateien/e_news_news.htm

 

OVIT used to own 78% of the issued and outstanding shares of AdnaGen*

 

* On November 2, 2010, OncoVista Innovative Therapies, Inc. (the "Company") entered into a Stock Purchase Agreement with Alere Holdings Bermuda Limited Canon's Court ("Alere Holdings"), whereby the Company sold all of its shares, representing approximately 78.01% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG ("AdnaGen").   Under the terms of the Stock Purchase Agreement, the Company and the other AdnaGen shareholders agreed to sell their respective shares of AdnaGen, and all AdnaGen related business assets, to Alere Holdings in consideration of: (i) a $10,000,000 up-front;  (ii) $10,000,000 in potential milestone payments contingent upon the achievement of various balance sheet objectives within 24 months; and (iii) up to $63,000,000 in potential milestone payments contingent upon the achievement of various clinical, regulatory and sales objectives within 36 months (collectively, the "Consideration").  The Company is entitled to receive its pro rata portion of approximately 78.01% of all Consideration.http://www.sec.gov/Archives/edgar/data/1094847/000114420410057309/v200923_8k.htm

 

----------------------

  

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001094847&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Share Structure:

Authorized Shares

147,397,390 as of September 30, 2011

 

Outstanding Shares

21,370,725 as of September 30, 2011

 

 

 

 


 

 


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 


 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

Digipath
OVIT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#596   Ok, it was not listed that way the gi197845 01/17/19 05:33:29 PM
#595   You mean the Aengus part I assume? That sharkgroupsn 01/17/19 05:22:36 PM
#594   What does this mean? https://www.bloomberg.com/research/stocks/private/snapshot. gi197845 01/17/19 05:08:55 PM
#593   9.5 out of 10. 3 reasons why: #1 sharkgroupsn 01/16/19 06:11:18 PM
#592   How confident are you on a scale of gi197845 01/16/19 05:54:26 PM
#591   Wish I knew when. Haven’t seen 300k volume sharkgroupsn 01/16/19 05:44:50 PM
#590   When will the new reverse shell merger with gi197845 01/16/19 05:35:35 PM
#589   No volume today, what's up with OVIT? gi197845 01/15/19 10:10:28 PM
#588   When will the new reverse shell merger with gi197845 01/14/19 09:23:13 PM
#587   Rather than investors just buying shares of a gi197845 01/11/19 11:12:01 PM
#586   Nice volume today. .10 right around the corner. sharkgroupsn 01/11/19 01:22:19 PM
#585   More sells today on low volume, oopsie. gi197845 01/10/19 06:01:16 PM
#584   More buys then sells yesterday on decent volume FWIW sharkgroupsn 01/10/19 09:25:39 AM
#583   Please explain how would a conflict of interest gi197845 01/08/19 07:16:08 PM
#582   Conflict of interest in this case would be sharkgroupsn 01/08/19 07:00:55 PM
#581   http://biochem.uthscsa.edu/faculty.php?displayID=45 gi197845 01/08/19 06:10:24 PM
#580   Ok, a conflict of interest sounds like a gi197845 01/08/19 06:02:03 PM
#579   Not sure if this has anything to do sharkgroupsn 01/08/19 05:45:12 PM
#578   Wow, let's of sells today... gi197845 01/08/19 05:16:09 PM
#577   Wow, someone bough 1,00 shares of Onco Vista gi197845 01/07/19 01:37:57 PM
#576   Maybe Monday will be the reverse shell merger gi197845 01/05/19 10:05:21 PM
#575   There was no year end announcement of a gi197845 12/31/18 09:39:11 PM
#574   EOY announcement? sharkgroupsn 12/28/18 12:52:15 PM
#573   Oh ya, baby! gi197845 12/26/18 04:30:42 PM
#572   Reverse shell merger is correct. IMO sharkgroupsn 12/19/18 07:56:04 AM
#571   Whoa, more volume today! Could a reverse shell gi197845 12/18/18 09:01:32 PM
#570   Ya, it will be a big win, win, win! gi197845 12/17/18 02:19:45 PM
#569   $1.75 in last big run. biotech2 12/16/18 05:38:48 PM
#568   Nice volume again. Bids stacking sharkgroupsn 12/14/18 05:46:49 PM
#567   LOOK AT EGBB, I own 500,000 shares at biotech2 12/13/18 04:33:10 PM
#566   All your points are valid except being the sharkgroupsn 12/13/18 04:22:11 PM
#565   Well, I would normally agree with your logic gi197845 12/13/18 03:50:10 PM
#564   Bankruptcy would’ve been done long ago and St sharkgroupsn 12/13/18 03:33:26 PM
#563   Hopefully, new technology is coming in and/or a gi197845 12/13/18 03:08:09 PM
#562   NEW TECHNOLGY COMING IN ? biotech2 12/13/18 02:40:39 PM
#561   Is something going on here? Why are we Stallion4life38 12/13/18 02:18:47 PM
#560   Trading has resumed, something is up biotech2 12/13/18 02:15:09 PM
#559   It looks like someone is trying to buy sharkgroupsn 12/13/18 10:20:31 AM
#558   Wow, another $750 worth of OVIT shares were gi197845 12/12/18 02:37:59 PM
#557   Wow, another $1,000 shares of OVIT were purchased today. gi197845 12/03/18 04:42:37 PM
#556   $525 dollars worth of OVIT shares were purchased today. gi197845 11/29/18 05:23:40 PM
#555   Good chance that’ll be the best $25 him/her sharkgroupsn 11/29/18 05:04:06 PM
#554   Wow, someone bought $25 dollars of OVIT stock. gi197845 11/29/18 01:53:58 PM
#553   Yes, about $3.50 worth of OVIT shares were gi197845 11/27/18 11:51:31 AM
#552   Big purchase!! sharkgroupsn 11/27/18 11:44:40 AM
#551   Wow, someone bought 225 shares of Onco Vista gi197845 11/27/18 11:20:04 AM
#550   Wow, volume today and yesterday. gi197845 11/20/18 11:08:05 AM
#549   How's that reverse shell merger coming along? gi197845 11/12/18 12:17:36 PM
#548   No volume today. gi197845 11/06/18 04:28:26 PM
#547   Or, could it be that Dr.Weis is already gi197845 10/29/18 10:31:50 AM
PostSubject